Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun 5;9(6):1753.
doi: 10.3390/jcm9061753.

COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge

Affiliations
Review

COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge

Jacek Baj et al. J Clin Med. .

Abstract

Coronavirus disease 2019 (COVID-19), due to the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has become an epidemiological threat and a worldwide concern. SARS-CoV-2 has spread to 210 countries worldwide and more than 6,500,000 confirmed cases and 384,643 deaths have been reported, while the number of both confirmed and fatal cases is continually increasing. COVID-19 is a viral disease that can affect every age group-from infants to the elderly-resulting in a wide spectrum of various clinical manifestations. COVID-19 might present different degrees of severity-from mild or even asymptomatic carriers, even to fatal cases. The most common complications include pneumonia and acute respiratory distress syndrome. Fever, dry cough, muscle weakness, and chest pain are the most prevalent and typical symptoms of COVID-19. However, patients might also present atypical symptoms that can occur alone, which might indicate the possible SARS-CoV-2 infection. The aim of this paper is to review and summarize all of the findings regarding clinical manifestations of COVID-19 patients, which include respiratory, neurological, olfactory and gustatory, gastrointestinal, ophthalmic, dermatological, cardiac, and rheumatologic manifestations, as well as specific symptoms in pediatric patients.

Keywords: Coronavirus disease 2019 (COVID-19); RNA; coronavirus; diagnosis; epidemic; outbreak; pandemics; public health; symptoms; the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The severity of SARS-CoV-2 infection with typical characteristics.

References

    1. World Health Organization (WHO) Statement on the Second Meeting of the International Health Regulations Emergency Committee Regarding the Outbreak of Novel Coronavirus (2019-nCoV) WHO; Geneva, Switzerland: 2005. [(accessed on 30 January 2020)]. Available online: https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-...
    1. World Health Organisation . WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19–11. WHO; Geneva, Switzerland: 2020. [(accessed on 12 March 2020)]. Available online: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-re....
    1. Setti L., Passarini F., De Gennaro G., Barbieri P., Pallavicini A., Ruscio M., Piscitelli P., Colao A., Miani A. Searching for SARS-COV-2 on Particulate Matter: A Possible Early Indicator of COVID-19 Epidemic Recurrence. Int. J. Environ. Res. Public Health. 2020;17:2986. doi: 10.3390/ijerph17092986. - DOI - PMC - PubMed
    1. Vincent J.-L., Taccone F.S. Understanding pathways to death in patients with COVID-19. Lancet Respir. Med. 2020;8:430–432. doi: 10.1016/S2213-2600(20)30165-X. - DOI - PMC - PubMed
    1. Nadeem M., Zamzami M., Choudhry H., Murtaza B., Kazmi I., Ahmad H., Shakoori A. Origin, Potential Therapeutic Targets and Treatment for Coronavirus Disease (COVID-19) Pathogens. 2020;9:307. doi: 10.3390/pathogens9040307. - DOI - PMC - PubMed

LinkOut - more resources